The Fly | KVUE

Kenvue, Inc.

· KVUE

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Over a week ago

Kimberly-Clark price target raised by $6 at Piper Sandler, here's why

Jun 17, 6:40 AM

Mondelez names Amit Banati as CFO

Jun 15, 4:46 PM

Starboard takes new stakes in Lamb Weston and CarMax, exits Autodesk position

+13

May 15, 4:47 PM

Kenvue reports Q1 adjusted EPS 32c, consensus 26c

KVUE

May 7, 6:31 AM

Notable companies reporting before tomorrow's open

+13

May 6, 2:55 PM

Kimberly-Clark announces organizational structure after acquisition of Kenvue

Apr 15, 9:01 AM

Kenvue price target lowered by $1 at Citi, here's why

KVUE

Apr 15, 6:31 AM

Kenvue price target lowered by $1 at Barclays, here's why

KVUE

Apr 14, 8:53 AM

Kenvue Inc call volume above normal and directionally bullish

KVUE

Apr 7, 2:45 PM

Kenvue price target lowered by $1 at UBS, here's why

KVUE

Apr 7, 6:42 AM

Kenvue price target raised by $1 at Barclays, here's why

KVUE

Mar 6, 5:46 AM

What You Missed On Wall Street On Thursday

+23

Feb 26, 4:26 PM

Judge spurns Kenvue bid to dismiss Texas lawsuit over Tylenol, Reuters reports

KVUE

Feb 26, 12:19 PM

Kenvue Inc call volume above normal and directionally bullish

KVUE

Feb 20, 3:45 PM

Kenvue rumor highlighted in Betaville blog

KVUE

Feb 20, 3:27 PM

Kenvue price target raised by $2 at UBS, here's why

KVUE

Feb 18, 7:42 AM

Kenvue price target raised by $1 at Canaccord, here's why

KVUE

Feb 18, 7:10 AM

Kenvue price target raised by $2 at Citi

KVUE

Feb 18, 6:34 AM

Kenvue reports Q4 EPS 27c, consensus 22c

KVUE

Feb 17, 4:47 PM

Starboard Value bought Clearwater and Fluor in Q4, sold Alight

+12

Feb 17, 4:18 PM

Kenvue Inc options imply 3.7% move in share price post-earnings

KVUE

Feb 17, 2:04 PM

Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls

+13

Jan 30, 9:54 AM

Jefferies downgrades Kenvue with deal closer to completion

Jan 30, 5:07 AM

Jefferies gets more bearish on Kenvue, downgrades shares

KVUE

Jan 29, 9:04 PM

Iconic Brand Portfolio and Market Leadership: Kenvue owns a powerful collection of highly recognized and trusted consumer health brands, including Tylenol, Neutrogena, Listerine, and Band-Aid, many of which hold leading positions in their respective categories globally.

Extensive Global Distribution Network: The company benefits from a vast and established global distribution network, ensuring its products are accessible to consumers across numerous markets worldwide, supporting diverse revenue streams.

Deep-Rooted Consumer Trust and Loyalty: Leveraging decades of heritage and association with Johnson & Johnson, Kenvue inherits a strong foundation of consumer trust, brand equity, and loyalty across its broad portfolio of health and wellness products.

Product Liability and Safety Concerns: The company faces inherent risks of product liability claims and product recalls if its consumer health products are found to be defective or cause harm, potentially leading to significant legal costs, settlements, and reputational damage.

Intense Competition and Market Share Erosion: Kenvue operates in highly competitive consumer health markets, facing pressure from established global players and emerging direct-to-consumer brands, which could lead to pricing pressure, reduced market share, and lower profitability if it fails to innovate or differentiate effectively.

Supply Chain Disruptions and Cost Volatility: Disruptions in the global supply chain, including raw material shortages, increased transportation costs, labor issues, or geopolitical events, could impact Kenvue's ability to manufacture and distribute its products, leading to higher operating costs and potential stock-outs.